Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | PAM | P19021 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL857453 | 0.88 | MEN1 (0.51) | MEN1KMT2ANR1H4ALDH1A1MAPT | |
| SCHEMBL857454 | 0.88 | MEN1 (0.51) | MEN1KMT2ANR1H4ALDH1A1MAPT | |
| SCHEMBL27619575 | 0.87 | MEN1 (0.50) | MEN1KMT2ANR1H4ALDH1A1MAPT | |
| SCHEMBL8954089 | 0.87 | MEN1 (0.50) | MEN1KMT2ANR1H4ALDH1A1MAPT | |
| SCHEMBL8954086 | 0.87 | MEN1 (0.50) | MEN1KMT2ANR1H4ALDH1A1MAPT | |
| SCHEMBL5612021 | 0.85 | KMT2A (0.49) | MEN1KMT2ANR1H4ALDH1A1MAPT | |
| SCHEMBL5612012 | 0.85 | KMT2A (0.49) | MEN1KMT2ANR1H4ALDH1A1MAPT | |
| SCHEMBL8159651 | 0.85 | L3MBTL1 (0.52) | MEN1KMT2ANR1H4ALDH1A1MAPT | |
| Ammonia Solution, Strong SCHEMBL27559312 | 0.84 | MEN1 (0.47) | MEN1KMT2ANR1H4ALDH1A1MAPT | |
| SCHEMBL5283363 | 0.82 | CYP3A4 (0.49) | MEN1KMT2AALDH1A1CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250376643-A1 | TREATMENT COMPOSITION WITH PERFUME-CONTAINING DELIVERY PARTICLES | ENCAPSYS, LLC (US) | 2025-12-11 | — | — | US | claimed |
| EP-4627029-A1 | TREATMENT COMPOSITION WITH PERFUME-CONTAINING DELIVERY PARTICLES | Encapsys, LLC (US) | 2025-10-08 | — | — | EP | claimed |
| EP-4626387-A1 | TREATMENT COMPOSITION WITH PERFUME CONTAINING DELIVERY PARTICLES | The Procter & Gamble Company (US) | 2025-10-08 | — | — | EP | claimed |
| US-20240306688-A1 | METHOD OF MITIGATING OFF-ODORS | GIVAUDAN SA (CH) | 2024-09-19 | — | — | US | claimed |
| EP-4391827-A1 | METHOD OF MITIGATING OFF-ODORS | Givaudan SA (CH) | 2024-07-03 | — | — | EP | claimed |
| WO-2024118699-A1 | TREATMENT COMPOSITION WITH PERFUME-CONTAINING DELIVERY PARTICLES | ENCAPSYS, LLC (US) | 2024-06-06 | — | — | WO | claimed |
| WO-2024118725-A1 | TREATMENT COMPOSITION WITH PERFUME CONTAINING DELIVERY PARTICLES | THE PROCTER & GAMBLE COMPANY (US) | 2024-06-06 | — | — | WO | claimed |
| US-20240182821-A1 | TREATMENT COMPOSITION WITH PERFUME-CONTAINING DELIVERY PARTICLES | THE PROCTER & GAMBLE COMPANY | 2024-06-06 | — | — | US | claimed |
| WO-2023025549-A1 | METHOD OF MITIGATING OFF-ODORS | GIVAUDAN SA (CH) | 2023-03-02 | — | — | WO | claimed |
| US-20190209441-A1 | GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOR | WELLA OPERATIONS US, LLC | 2019-07-11 | — | — | US | claimed |
| US-20190192408-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | WELLA OPERATIONS US, LLC | 2019-06-27 | — | — | US | claimed |
| US-20190175476-A1 | HAIR COLORING OR BLEACHING COMPOSITION WITH REDUCED ODOR | WELLA OPERATIONS US, LLC | 2019-06-13 | — | — | US | claimed |
| WO-2018053183-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | NOXELL CORPORATION (US) | 2018-03-22 | — | — | WO | claimed |
| WO-2018053065-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | THE PROCTER & GAMBLE COMPANY (US) | 2018-03-22 | — | — | WO | claimed |
| EP-3295925-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | Noxell Corporation (US) | 2018-03-21 | — | — | EP | claimed |
| WO-2018048924-A1 | GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOR | NOXELL CORPORATION (US) | 2018-03-15 | — | — | WO | claimed |
| WO-2018048933-A1 | HAIR COLORING OR BLEACHING COMPOSITION WITH REDUCED ODOR | NOXELL CORPORATION (US) | 2018-03-15 | — | — | WO | claimed |
| EP-3290085-A1 | HAIR COLOURING OR BLEACHING COMPOSITION WITH REDUCED ODOUR | Noxell Corporation (US) | 2018-03-07 | — | — | EP | claimed |
| EP-3290086-A1 | GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOUR | Noxell Corporation (US) | 2018-03-07 | — | — | EP | claimed |
| US-20250376643-A1 | TREATMENT COMPOSITION WITH PERFUME-CONTAINING DELIVERY PARTICLES | ENCAPSYS, LLC (US) | 2025-12-11 | — | — | US | disclosed |
| EP-4626387-A1 | TREATMENT COMPOSITION WITH PERFUME CONTAINING DELIVERY PARTICLES | The Procter & Gamble Company (US) | 2025-10-08 | — | — | EP | disclosed |
| EP-3290085-B1 | HAIR COLOURING OR BLEACHING COMPOSITION WITH REDUCED ODOUR | WELLA OPERATIONS US LLC (US) | 2024-11-06 | — | — | EP | disclosed |
| US-20240306688-A1 | METHOD OF MITIGATING OFF-ODORS | GIVAUDAN SA (CH) | 2024-09-19 | — | — | US | disclosed |
| EP-4391827-A1 | METHOD OF MITIGATING OFF-ODORS | Givaudan SA (CH) | 2024-07-03 | — | — | EP | disclosed |
| US-20240182821-A1 | TREATMENT COMPOSITION WITH PERFUME-CONTAINING DELIVERY PARTICLES | THE PROCTER & GAMBLE COMPANY | 2024-06-06 | — | — | US | disclosed |
| WO-2024118725-A1 | TREATMENT COMPOSITION WITH PERFUME CONTAINING DELIVERY PARTICLES | THE PROCTER & GAMBLE COMPANY (US) | 2024-06-06 | — | — | WO | disclosed |
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-02-08 | — | — | US | disclosed |
| EP-4288022-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2023-12-13 | — | — | EP | disclosed |
| US-11779530-B2 | Composition for the permanent deformation of hair having reduced odor | WELLA OPERATIONS US, LLC (US) | 2023-10-10 | — | — | US | disclosed |
| US-11771633-B2 | Hair coloring or bleaching composition with reduced odor | WELLA OPERATIONS US, LLC (US) | 2023-10-03 | — | — | US | disclosed |
| US-11696877-B2 | Gel network hair treatment compositions with reduced odor | WELLA OPERATIONS US, LLC (US) | 2023-07-11 | — | — | US | disclosed |
| WO-2023025549-A1 | METHOD OF MITIGATING OFF-ODORS | GIVAUDAN SA (CH) | 2023-03-02 | — | — | WO | disclosed |
| WO-2022167123-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2022-08-11 | — | — | WO | disclosed |
| EP-3290086-B1 | GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOUR | WELLA OPERATIONS US LLC (US) | 2022-07-27 | — | — | EP | disclosed |
| EP-3295925-B2 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | NOXELL CORP (US) | 2022-05-18 | — | — | EP | disclosed |
| EP-3295925-B1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | NOXELL CORP (US) | 2019-09-11 | — | — | EP | disclosed |
| US-20190209441-A1 | GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOR | WELLA OPERATIONS US, LLC | 2019-07-11 | — | — | US | disclosed |
| US-20190192408-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | WELLA OPERATIONS US, LLC | 2019-06-27 | — | — | US | disclosed |
| US-20190175476-A1 | HAIR COLORING OR BLEACHING COMPOSITION WITH REDUCED ODOR | WELLA OPERATIONS US, LLC | 2019-06-13 | — | — | US | disclosed |
| EP-2496682-B1 | DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2019-03-20 | — | — | EP | disclosed |
| WO-2018053183-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | NOXELL CORPORATION (US) | 2018-03-22 | — | — | WO | disclosed |
| WO-2018053065-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | THE PROCTER & GAMBLE COMPANY (US) | 2018-03-22 | — | — | WO | disclosed |
| EP-3295925-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | Noxell Corporation (US) | 2018-03-21 | — | — | EP | disclosed |
| WO-2018048924-A1 | GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOR | NOXELL CORPORATION (US) | 2018-03-15 | — | — | WO | disclosed |
| US-20180071188-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | THE PROCTER & GAMBLE COMPANY | 2018-03-15 | — | — | US | disclosed |
| WO-2018048933-A1 | HAIR COLORING OR BLEACHING COMPOSITION WITH REDUCED ODOR | NOXELL CORPORATION (US) | 2018-03-15 | — | — | WO | disclosed |
| EP-3290085-A1 | HAIR COLOURING OR BLEACHING COMPOSITION WITH REDUCED ODOUR | Noxell Corporation (US) | 2018-03-07 | — | — | EP | disclosed |
| EP-3290086-A1 | GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOUR | Noxell Corporation (US) | 2018-03-07 | — | — | EP | disclosed |
| US-8629126-B2 | Quinolone derivative or pharmaceutically acceptable salt thereof | ASTELLAS PHARMA INC. (JP) | 2014-01-14 | — | — | US | disclosed |
| US-8629126-B2 | Quinolone derivative or pharmaceutically acceptable salt thereof | ASTELLAS PHARMA INC. (JP) | 2014-01-14 | — | — | US | disclosed |
| US-8357649-B2 | Delivery particle | THE PROCTER & GAMBLE COMPANY (US) | 2013-01-22 | — | — | US | disclosed |
| EP-2496682-A1 | DELIVERY PARTICLE | The Procter & Gamble Company (US) | 2012-09-12 | — | — | EP | disclosed |
| US-20120136025-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2012-05-31 | — | — | US | disclosed |
| US-20120136025-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2012-05-31 | — | — | US | disclosed |
| US-8133882-B2 | Quinolone derivative or pharmaceutically acceptable salt thereof | ASTELLAS PHARMA INC (JP) | 2012-03-13 | — | — | US | disclosed |
| US-8133882-B2 | Quinolone derivative or pharmaceutically acceptable salt thereof | ASTELLAS PHARMA INC (JP) | 2012-03-13 | — | — | US | disclosed |
| EP-1995240-B1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ASTELLAS PHARMA INC (JP) | 2012-02-22 | — | — | EP | disclosed |
| EP-2346535-A1 | MALODOR CONTROL SYSTEM | The Procter & Gamble Company (US) | 2011-07-27 | — | — | EP | disclosed |
| US-20110107524-A1 | DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY | 2011-05-12 | — | — | US | disclosed |
| WO-2011056935-A1 | DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY (US) | 2011-05-12 | — | — | WO | disclosed |
| WO-2010053891-A1 | MALODOR CONTROL SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 2010-05-14 | — | — | WO | disclosed |
| US-20100111889-A1 | Malodor Control System | PROCTER & GAMBLE COMPANY, THE | 2010-05-06 | — | — | US | disclosed |
| US-20090197834-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2009-08-06 | — | — | US | disclosed |
| US-20090197834-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2009-08-06 | — | — | US | disclosed |
| EP-2037735-A2 | MULTI-COMPONENT INSECT ATTRACTANT | Farma Tech International Corporation (US) | 2009-03-25 | — | — | EP | disclosed |
| EP-1995240-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Astellas Pharma Inc. (JP) | 2008-11-26 | — | — | EP | disclosed |
| WO-2007149531-A2 | MULTI-COMPONENT INSECT ATTRACTANT | FARMA TECH INTERNATIONAL CORPORATION (US) | 2007-12-27 | — | — | WO | disclosed |
| US-20070292467-A1 | Multi-component insect attractant | FARMA TECH INTERNATIONAL CORPORATION | 2007-12-20 | — | — | US | disclosed |
| US-20070292467-A1 | Multi-component insect attractant | FARMA TECH INTERNATIONAL CORPORATION | 2007-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120136025-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | P2RY10, P2RY12, P2RY11 | MEN1 3327/4885KMT2A 2966/4885NR1H4 1596/4885 |
| US-20180071188-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | MAL2, MSH6, OR51E2 | MEN1 2628/4885KMT2A 3055/4885NR1H4 279/4885 |
| US-20190192408-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | MAL2, MSH6, OR51E2 | MEN1 2628/4885KMT2A 3055/4885NR1H4 279/4885 |
| US-11779530-B2 | Composition for the permanent deformation of hair having reduced odor | OR51E2, MAL2, OR10J3 | MEN1 2717/4885KMT2A 2931/4885NR1H4 122/4885 |
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | AOX1, TYR, OCIAD1 | MEN1 1002/4885KMT2A 4016/4885NR1H4 3191/4885 |
| US-20090197834-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | P2RY12, P2RY11, P2RY10 | MEN1 2994/4885KMT2A 2967/4885NR1H4 2261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.